Melanin Nanomedicines Target Inflammation via Myeloperoxidase
Researchers develop a melanin nanomedicine platform that targets inflamed tissues using myeloperoxidase to treat chronic inflammation.
This story has stopped developing; this page is its permanent record. More from that day
Sources
Every article we clustered into this story. Headlines link to the publisher.